| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.13 | 2e-05 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.14 | 4e-05 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.13 | 7e-05 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0001 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.17 | 0.0006 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0008 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.17 | 0.001 |